thiotepa has been researched along with Adenocarcinoma, Papillary in 3 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deutsch, M | 1 |
| Parsons, JA | 1 |
| Furnari, S | 1 |
| Lattuca, C | 1 |
| Pavone-Macaluso, M | 1 |
| Leone, G | 1 |
| Frick, HC | 1 |
3 other studies available for thiotepa and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
Thio-TEPA and supervoltage radiotherapy for carcinoma of the ovary.
Topics: Adenocarcinoma, Papillary; Carcinoma; Cystadenocarcinoma; Cystadenoma; Evaluation Studies as Topic; | 1972 |
[Intravascular thio-tepa in the treatment of papillary neoplasms of the bladder].
Topics: Adenocarcinoma, Papillary; Carcinoma, Papillary; Humans; Papilloma; Thiotepa; Urinary Bladder Neopla | 1968 |
Over-all evaluation of chemotherapy for ovarian cancer.
Topics: Adenocarcinoma, Papillary; Adolescent; Adult; Alkylating Agents; Antineoplastic Agents; Female; Huma | 1969 |